Join our community of traders FOR FREE!

  • Learn
  • Improve yourself
  • Get Rewards
Learn More

Arthur J. Gallagher & Co, a global insurance brokerage, risk management and consulting services company, said on Monday that its reinsurance unit, Gallagher Re, had acquired the business and assets of UK’s Bay Risk Services Limited.

However, financial terms of the agreement remained undisclosed.

Bay Risk, which was established in 2016, specializes in structuring and placing contracts of delegated underwriting authority and serves niche program managers, managing general agents and Lloyd’s coverholders.

The business will become part of the global programs practice of Gallagher Re, the company said.

“Bay Risk is a highly regarded specialist binder broker that will be a fantastic addition to Gallagher Re and the expanding global programs practice,” J. Patrick Gallagher, Jr., Chairman, President and Chief Executive Officer of Arthur J. Gallagher & Co, said in a press release.

“It shares our focus on client excellence and brings a complementary book of delegated underwriting authority business. We are delighted to welcome Andrew, Robin and their colleagues to our growing global team,” the CEO added.

TradingPedia.com is a financial media specialized in providing daily news and education covering Forex, equities and commodities. Our academies for traders cover Forex, Price Action and Social Trading.

Related News

  • Forex Market: EUR/CAD daily forecastForex Market: EUR/CAD daily forecast During yesterday’s trading session EUR/CAD traded within the range of 1.5027-1.5120 and closed at 1.5086.At 7:13 GMT today EUR/CAD was losing 0.16% for the day to trade at 1.5054. The pair touched a daily low at 1.5050 at 7:12 […]
  • Onyx rejects Amgen offer, still looking for a mergerOnyx rejects Amgen offer, still looking for a merger Onyx Pharmaceuticals, the bio-pharmaceutical company developing cancer drugs, rejected an acquisition offer from Amgen the world largest independant bio-pharmaceutical firm for around $10 billion. The company stated it is waiting on better […]
  • Forex Market: GBP/USD daily trading outlookForex Market: GBP/USD daily trading outlook Friday’s trade saw GBP/USD within the range of 1.4504-1.4647. The pair closed at 1.4520, falling 0.67% on a daily basis. It has been the eighth drop in the past nine trading days and also a sixth consecutive one. The daily low has been the […]
  • Glencore share price up, S&P downgrades outlook to negativeGlencore share price up, S&P downgrades outlook to negative Ratings agency Standard and Poors cut its outlook for Glencore Plc to negative from stable after the London-listed company reported a hefty drop in first-half profit and lowered its projections for commodity prices.The negative revision […]
  • Apple’s progress in China threatened by big screens demandApple’s progress in China threatened by big screens demand Apple Inc. is currently facing a real challenge while trying to boost its share on the Chinese market by selling handsets through China Mobile Ltd. starting Friday. The companys difficulties come from the fact that a large number of Chinese […]
  • Pfizer share price down, projects lower sales on stronger dollarPfizer share price down, projects lower sales on stronger dollar Pfizer Inc announced on Tuesday it expects a drop in sales this year as the largest US drugmaker reported a decline in revenue during the fourth quarter.Pfizer stated a revenue of $13.12 billion during the three months ended December 31, […]